ID   KO_2
AC   CVCL_F6KR
SY   mNPC Parkin KO_2
RX   PubMed=41959321;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1355296; Prkn.
CC   Derived from site: In situ; Brain, forebrain; UBERON=UBERON_0001890.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 Atrxfl/fl x B6.129S2-Trp53tm1Tyj/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F6KP ! mNPC
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-10-26; Last updated: 22-10-26; Version: 1
//
RX   PubMed=41959321; DOI=10.64898/2026.04.01.715918; PMCID=PMC13060259;
RA   Gong, Yongxing
RA   Bayati, Armin
RA   Alban, Tyler J.
RA   Parthasarathy, Prerana
RA   Zhou, Fang
RA   Makarov, Vladimir
RA   Zhao, Yuhang
RA   Su, Chienwen
RA   Schumacher, Jackson G.
RA   Singh, Vijay
RA   Volpicelli-Daley, Laura A.
RA   Luo, Wen
RA   Durcan, Thomas M.
RA   Dutta, Shovan
RA   Schwarzschild, Michael A.
RA   Johnston, Jennifer A.
RA   Chan, Timothy A.
RA   Chen, Xiqun
RT   "Neural cell state modulation by PARK2 and dopaminergic
RT   neuroprotection by small molecule Parkin agonism.";
RL   bioRxiv no_volume:2026.04.01.715918-2026.04.01.715918(2026).
//